OUR PRODUCTS

MOBILE APPS

GENERAL INFO

MRSN

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Mersana Therapeutics (MRSN) Earnings Date & Reports

Mersana Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing antibody-drug conjugates (ADCs) that offer a clinically meaningful benefit for cancer patients with unmet needs... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

MRSN is expected to report earnings to fall 97.06% to -14 cents per share on November 11

Mersana Therapeutics MRSN Stock Earnings Reports

Q3'25

Est.

$-0.14

Q2'25

Missed

by $4.71

Q1'25

Est.

$-0.19

Q4'24

Beat

by $0.04

Q3'24

Missed

by $0.18

The last earnings report on August 13 showed earnings per share of -486 cents, missing the estimate of -15 cents. With 40.77K shares outstanding, the current market capitalization sits at 38.23M.

View a ticker or compare two or three

Compare

MRSN

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For MRSN
(Try 14 days for Free)

Interact to see
Advertisement

A.I.Advisor

published price charts

These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. MRSN showed earnings on August 13, 2025. You can read more about the earnings report here.

View AI-Driven Trading

A.I. Advisor

published General Information

General Information

a developer of antibody drug conjugates to improve patient outcomes in multiple oncology indications

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Biotechnology

Address

840 Memorial Drive

Phone

+1 617 498-0020

Employees

123

Web

https://www.mersana.com